Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ISI names new managing director of Europe
Mr Sherlock replaces Gilbert Kampfner, who is retiring after almost nine years with the company. Mr Sherlock, who joined ISI as director of business development in 2007, has
Mr Sherlock replaces Gilbert Kampfner, who is retiring after almost nine years with the company. Mr Sherlock, who joined ISI as director of business development in 2007, has
Mr Tsolinas currently serves as chairman and CEO of TMA Group Development, a Chicago-based real estate, architectural and development firm. Mr Tsolinas has earned a BA degree in
This patent-pending kit contains proprietary reagents, consumable processing containers (Pulse Tubes), and instructions for use, and is intended to be used with the company’s patented pressure cycling technology
Enobia is investigating enzyme replacement therapy (ERT) with ENB-0040 for the treatment of this genetic bone disorder for which there is no approved treatment. Under two separate protocols,
Many protocols for inducing the development embryonic and induced pluripotent stem cells into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are three-dimensional
With over 35 years of experience, Mr Phairas brings a wide variety of skills and experience from the high technology industry including executive positions with Fortune 500 companies,
The shares were issued at a price of $0.95 per share, with each investor also receiving warrants to purchase the number of shares of class A common stock
The investigational new drug (IND) application is for a Phase I safety and immunogenicity study of this influenza vaccine in healthy volunteers. The filing initiates a 30-day review
According to the company, Pass Rx employs patented sensor technologies to generate a unique spectral fingerprint and image data of the size, color and shape of the drug.
With the extension of the agreement, Healthways and the Premera companies will continue their innovative care support program that links customizable disease management solutions with faster and more